Singapore markets closed

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)

Vienna - Vienna Delayed price. Currency in EUR
Add to watchlist
48.64+1.16 (+2.44%)
As of 09:05AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 9.99B
Enterprise value 11.58B
Trailing P/E 25.51
Forward P/E 17.27
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.77
Price/book (mrq)5.81
Enterprise value/revenue 5.56
Enterprise value/EBITDA 16.52

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 310.62%
S&P500 52-week change 323.49%
52-week high 353.20
52-week low 341.95
50-day moving average 350.37
200-day moving average 348.28

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5206.41M
Implied shares outstanding 6210.41M
Float 899.23M
% held by insiders 151.82%
% held by institutions 129.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.26
Forward annual dividend yield 42.65%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 32.53%
5-year average dividend yield 42.41
Payout ratio 462.87%
Dividend date 323 Aug 1970
Ex-dividend date 417 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.18%
Operating margin (ttm)31.20%

Management effectiveness

Return on assets (ttm)9.70%
Return on equity (ttm)22.40%

Income statement

Revenue (ttm)2.14B
Revenue per share (ttm)10.39
Quarterly revenue growth (yoy)10.20%
Gross profit (ttm)N/A
EBITDA 774.23M
Net income avi to common (ttm)388.86M
Diluted EPS (ttm)1.86
Quarterly earnings growth (yoy)-0.30%

Balance sheet

Total cash (mrq)294.65M
Total cash per share (mrq)1.43
Total debt (mrq)1.74B
Total debt/equity (mrq)95.96%
Current ratio (mrq)1.36
Book value per share (mrq)8.81

Cash flow statement

Operating cash flow (ttm)528.44M
Levered free cash flow (ttm)75.03M